Compare RNXT & WWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RNXT | WWR |
|---|---|---|
| Founded | 2012 | 1977 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.0M | 76.7M |
| IPO Year | 2021 | 2006 |
| Metric | RNXT | WWR |
|---|---|---|
| Price | $0.85 | $0.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $8.25 | $1.92 |
| AVG Volume (30 Days) | 305.7K | ★ 879.3K |
| Earning Date | 05-14-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.00 | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $1,123,000.00 | N/A |
| Revenue This Year | $194.66 | N/A |
| Revenue Next Year | $279.78 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 2511.63 | N/A |
| 52 Week Low | $0.70 | $0.45 |
| 52 Week High | $1.45 | $3.75 |
| Indicator | RNXT | WWR |
|---|---|---|
| Relative Strength Index (RSI) | 34.66 | 42.75 |
| Support Level | $0.82 | $0.58 |
| Resistance Level | $1.07 | $0.73 |
| Average True Range (ATR) | 0.06 | 0.04 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 5.78 | 31.28 |
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
Westwater Resources Inc focused on developing battery-grade natural graphite materials. The company is having one project which is the Westwater's coosa project which is currently used for the mining and extraction of graphite.